Nicotine Replacement Therapy: Methods, Effectiveness & Use
This paper provides an overview of nicotine replacement therapy (NRT) as a smoking cessation and harm reduction strategy. It examines the history and rationale of NRT, explaining how various delivery methods — including transdermal patches, chewing gum, nasal sprays, inhalers, lozenges, and e-cigarettes — work to reduce nicotine withdrawal symptoms without the harmful byproducts of tobacco combustion. The paper discusses the effectiveness of each method, noting that commercially available NRT products increase long-term cessation rates by approximately 50–70%. Special considerations for pregnant women, highly dependent smokers, and light smokers are also addressed, along with guidance on dosage selection and the role of behavioral support alongside NRT use.
- Introduction to Nicotine Replacement Therapy: Defines NRT and its harm reduction role
- How NRT Products Are Absorbed: Explains pharmacological delivery mechanisms of NRT
- Effectiveness of NRT Across Settings: Reviews cessation rate improvements and population caveats
- Use of Nicotine Patches: Patch dosage, duration, side effects, and recommendations
- Use of Nicotine Gum: Gum dosage strengths, absorption, and usage guidance
- Use of E-Cigarettes: E-cigarette use, cessation impact, and safety concerns
- Conclusion: Summarizes NRT effectiveness and support recommendations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Organizes NRT methods systematically, moving from an overview of the field to specific product types, making the paper easy to follow and compare across methods.
- Grounds effectiveness claims in quantitative data (e.g., 50–70% improvement in cessation rates) drawn from peer-reviewed sources including a Cochrane Library review.
- Addresses nuanced populations — pregnant women, highly dependent smokers, and light smokers — showing awareness that NRT is not a one-size-fits-all solution.
Key academic technique demonstrated
The paper demonstrates effective use of a single authoritative source (Stead et al., 2012, Cochrane Library) as a backbone for multiple related claims, while supplementing it with additional studies for specific subtopics such as pregnancy, e-cigarettes, and harm reduction. This layered citation strategy shows how to build a literature-supported argument without over-relying on a single reference.
Structure breakdown
The paper opens with a definition of NRT and harm reduction principles, then explains the pharmacological basis for NRT delivery methods. It proceeds through individual product types — patches, gum, and e-cigarettes — each as a labeled subsection with its own effectiveness evidence and practical guidance. A brief conclusion synthesizes the key takeaway that NRT meaningfully improves cessation success rates regardless of support intensity.
Introduction to Nicotine Replacement Therapy
Nicotine replacement therapy (NRT) — including nicotine patches, gum, nasal spray, inhalers, and lozenges — is a way to deliver nicotine to the body without the use of tobacco, helping people cease smoking. NRT was first made widely available over the counter in several countries during the 1990s. While many smokers trying to quit do not use cessation medication, those who do tend to prefer over-the-counter NRT solutions (Bo Zhang, Joanna E. Cohen, Susan J. Bondy, & Peter Selby, 2014).
Harm reduction seeks to reduce smoking's negative effects without requiring complete cessation. This can be achieved in several ways, including complete or partial cigarette substitution with safer NRT products. Partial replacement involves using NRT as a means of achieving smoking reduction — that is, reducing the number of cigarettes smoked per day. NRT can also be used to achieve temporary abstinence. Complete substitution, by contrast, involves using NRT to totally replace all cigarettes and is primarily employed to prevent relapse (Kabay Silla, Emma Beard, & Lion Shahab, 2014).
How NRT Products Are Absorbed
The goal of NRT is to reduce the withdrawal symptoms associated with stopping smoking by replacing the nicotine that cigarettes previously provided. NRT can take the form of skin patches, which slowly deliver nicotine to the brain, or faster-acting forms such as oral and nasal sprays, inhalers, tablets and lozenges, and chewing gum. These faster-acting forms deliver nicotine more quickly than patches but more slowly than a smoked cigarette.
Nicotine that undergoes first-pass metabolism in the liver has reduced overall bioavailability when swallowed. A pill producing high levels of nicotine reliably in the central nervous system can also cause gastrointestinal problems. For this reason, NRT products are designed to be absorbed via the nasal or oral mucosa — through sublingual tablets, inhalers, sprays, lozenges, and chewing gum — or via the skin through transdermal patches (Lindsay F. Stead et al., 2012).
Effectiveness of NRT Across Settings
All commercially available NRT options — patches, nasal spray, lozenges, and inhalers — are effective aids for smokers who wish to quit. Regardless of the setting, these products increase long-term cessation rates by approximately 50% to 70%. This applies both to self-motivated smokers and to those who are highly dependent on nicotine. Evidence on the role of NRT for smokers who consume fewer than ten to fifteen cigarettes per day is limited. The choice of product should be guided by the patient's specific needs, tolerability, and ability to pay (Lindsay F. Stead et al., 2012).
In pregnant women, NRT success rates are comparable to those of behavioral therapy alone. NRT can be more effective when combined — for instance, pairing a patch with a faster-acting option. However, nicotine is classified as a Category D substance during pregnancy, and person-to-person psychological intervention is the recommended first-line approach (Tywanda Mclaurin-Jones & Folasade Osagie, 2014).
Conclusion
All commercially available NRT products — including nasal spray, sublingual tablets and lozenges, inhalers, and transdermal patches — can help smokers successfully quit smoking. Using NRT increases the likelihood of cessation success by 50% to 70%. Because their effectiveness is not significantly diminished by lower levels of supplementary support, NRT products can be quite effective even in lower-support settings. While it remains beneficial to provide behavioral support to those using NRT, it is not an essential requirement for success (Lindsay F. Stead et al., 2012).
References
Bo Zhang, Joanna E. Cohen, Susan J. Bondy, & Peter Selby. (2014). Duration of nicotine replacement therapy use and smoking cessation: A population-based longitudinal study. American Journal of Epidemiology.
Emma Beard, Robert West, Susan Michie, & Jamie Brown. (2016). Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: Time series analysis of population trends. BMJ.
Farsalinos, K. (2014). Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: A systematic review. Therapeutic Advances in Drug Safety, 67–86.
Kabay Silla, Emma Beard, & Lion Shahab. (2014). Nicotine replacement therapy use among smokers and ex-smokers: Associated attitudes and beliefs — a qualitative study. BMC Public Health.
Lindsay F. Stead, Rafael Perera, Chris Bullen, David Mant, Jamie Boyce, Kate Cahill, & Tim Lancaster. (2012). Nicotine replacement therapy for smoking cessation. The Cochrane Library.
Mirken, B. (2016). Nicotine patches and chewing gum. Healthday.
Tywanda Mclaurin-Jones & Folasade Osagie. (2014). For pregnant patients who smoke, is nicotine replacement therapy more effective than counseling or no intervention for achieving successful smoking cessation? CME Evidence-Based Practice — A Peer-Reviewed Publication of the Family Physicians Inquiries Network.
Create your account
Always verify citation format against your institution’s current style guide requirements.